首页> 外文会议>Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XIX >In vivo sampling of Verteporfin uptake in pancreas cancer xenograft models: comparison of surface, oral and interstitial measurements
【24h】

In vivo sampling of Verteporfin uptake in pancreas cancer xenograft models: comparison of surface, oral and interstitial measurements

机译:胰腺癌异种移植模型中Verteporfin吸收的体内采样:表面,口腔和间质测量值的比较

获取原文
获取原文并翻译 | 示例

摘要

Photodynamic therapy (PDT) mediated with Verteporfin is being investigated as a pancreatic cancer treatment in the cases for non-surgical candidates. Tissue response to PDT is based on a number of parameters including photosensitizer (PS) dose, light dose and time interval between light application and PS injection.rnIn this study, PS uptake and distribution in animal leg muscle, oral cavity tissues, pancreas and tumor was measured in vivo using light-induced fluorescence spectroscopy (LIFS) via an Aurora Optics Inc. PDT fluorescence dosimeter. An orthotopic pancreatic cancer model (AsPC-1) was implanted in SCID mice and treated with the PS. Probe measurements were made using a surface probe and an interstitial needle probe before and up to one hour after intravenous tail vein injection of the PS.rnThe study demonstrated that it is possible to correlate in-vivo LIFS measurements of the PS uptake in the pancreas with measurements taken from the oral cavity indicating that light dosimetry of PDT of the pancreas can be ascertained from the LIFS measurements in the oral cavity. These results emphasize the importance of light dosimetry in improving the therapeutic outcome of PDT through light dose adaptation to the relative in situ tissue PS concentration.
机译:对于非手术候选人,正在研究用Verteporfin介导的光动力疗法(PDT)作为胰腺癌的治疗方法。组织对PDT的反应取决于许多参数,包括光敏剂(PS)剂量,光剂量以及光照射和PS注射之间的时间间隔。在这项研究中,PS在动物腿部肌肉,口腔组织,胰腺和肿瘤中的摄取和分布使用Aurora Optics Inc.的PDT荧光剂量计通过光诱导荧光光谱法(LIFS)在体内进行测定。将原位胰腺癌模型(AsPC-1)植入SCID小鼠中,并用PS治疗。静脉注射尾静脉之前和之后一小时,使用表面探针和间质针探针进行探针测量。研究表明,将胰腺中PS摄取的体内LIFS测量与肝脏内LIFS测量相关联是可能的。从口腔进行的测量表明,可以从口腔中的LIFS测量确定胰腺PDT的光剂量。这些结果强调了光剂量测定在通过光剂量适应相对原位组织PS浓度来改善PDT治疗结果中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号